![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, July 18, 2022 3:09:57 PM
8:45a ET 7/18/2022 - Dow Jones
Acer Therapeutics Resubmits FDA Application for ACER-001 >ACER
Mentioned: ACER
By Colin Kellaher
Acer Therapeutics Inc. on Monday said it has once again filed for U.S. Food and Drug Administration approval of ACER-001 for the treatment of patients with urea cycle disorders.
The FDA in June rejected Acer's application for its lead drug candidate after the agency couldn't complete an inspection of a third-party contract packaging manufacturer because its plant wasn't ready for inspection.
Acer, a Newton, Mass., pharmaceutical company that is developing ACER-001 in collaboration with Switzerland's Relief Therapeutics Holding SA, said it believes the resubmission addresses the FDA's concerns in full, adding that the contract manufacturer is now ready for inspection by the agency.
Acer said it expects notification of the FDA's decision to accept or reject the resubmission for review within 14 days of the agency's receipt.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
July 18, 2022 08:45 ET (12:45 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM